Additionally, it dramatically increased antibody titer by up to 128-fold in vivo, compared to the codon-optimization benchmark mRNA sequence H.

Users can now freely select a solution that meets their needs, including protein purification and characterization, gene synthesis, codon optimization, small-scale testing, and scale-up.